Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study. Article uri icon

Overview

publication date

  • July 1, 2016

Identity

Scopus Document Identifier

  • 84976292847

Digital Object Identifier (DOI)

  • 10.1007/s11060-016-2153-6

PubMed ID

  • 27270719

Additional Document Info

volume

  • 128

issue

  • 3